Medicines and Healthcare Products Regulatory Agency

The Commissioner’s decision is that section 14(1) of FOIA is engaged in respect of two requests the complainant submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) for correspondence about COVID-19 vaccine developers. That requests can be categorised as vexatious due to the disproportionate burden that complying with them would cause to MHRA. It is not necessary for MHRA to take any steps.